Regular ArticleAn Australian experience with temozolomide for the treatment of recurrent high grade gliomas
References (14)
- et al.
Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours
Eur J Cancer
(1993) - American Cancer Society, SEER statistics,...
Canstat 1994
(1997)- et al.
New chemotherapy options for the treatment of malignant gliomas
Curr Opin Oncol
(1999) Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading
Neuro-Oncology
(1999)- et al.
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials
J Clin Oncol
(1999) - et al.
Phase 1 trial of temozolomide
Br J Cancer
(1992)
There are more references available in the full text version of this article.
Cited by (0)
- f1
Correspondence to: Mark Rosenthal, Department of Clinical Haematology and Medical Oncology, Royal Melbourne Hospital, Parkville, Victoria, 3052 Australia. Tel.: 61 3 9342 7560; Fax: 61 3 9347 7508; E-mail:[email protected]
Copyright © 2001 Harcourt Publishers Ltd. All rights reserved.